ENDOMETRİYAL HİPERPLAZİLERDE TANI VE TEDAVİ

2005 · vol. 8(3) , pp. 81–85 · W2980802629
article OA: green CC0
🔓 Open OA copy View on OpenAlex

Abstract

Endometrial hyperplasia is an important clinical pathology because of causing abnormal uterine bleeding, has been seen by tumour which is secreting estrogen, after hormonal treatment and with endometrial cancer or before endometrial cancer as a precancerous lesion. Cervicovaginal and endometrial cytology are insufficient in diagnosis. Endometrial tissue sampling is the gold standard in the diagnosis of endometrial hyperplasia. In postmenapausal woman in cases in which the endometrial thickness is 5 mm or above in the transvaginal ultrasonography; endometrial biopsy can be used for screening. In premenapausal woman the endometrial thickness threshold level is 8-10 mm or above. The treatment can be planned by looking patients age, histological type and reproductive condition. Treatment modalities can be examined in 2 ways; medical and surgical: In medical treatment progesterone, oral contraceptives, danazol and GnRH analogues are used. In surgical treatment D&C, hysterectomy, hysteroscopic endometrial ablasion or endometrial resection can be used.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK